DOI: 10.7241/ourd.20124.84 article in PDF
Our Dermatol Online. 2012; 3(4): 364
Date of submission: 06.06.2012 / acceptance: 13.06.2012
Conflicts of interest: None
HURLEY DISEASE – SHORT COMMENT
Anca Chiriac1, Liliana Foia2, Tudor Pinteala3, Anca E. Chiriac4
1CMI Dermatology-Iasi,Romania
2Univ.of Medicine Gr T Popa, Biochemistry Department, Iasi-Romania
3Imperial College of London, UK
4Univ.of Medicine Gr T Popa Iasi-Romania
Corresponding author: Anca Chiriac, MD PhD e-mail: ancachiriac@yahoo.com
How to cite an article: Chiriac A, Foia L, Pinteala T, Chiriac AE. Hurley disease. Our Dermatol Online. 2012; 3(4): 363.
Short comment to a previous article:
Chiriac A, Foia L, Pinteala T, Chiriac AE: Acne inversa (Hurley clinical stage ii): case report. Our Dermatol Online. 2011; 2(4): 215-216.
Sir,
The patient refused the surgery and we recommended him resorcinol 30% in vaseline, vitamin C high doses orally (2g/day) and a two-month treatment with Sultametoxazol 4cp/day (Biseptol, Cotrimoxazol) plus Rifampicine 300 mg/ day, with very good results (as seen in the picture).
Unfortunatly we were obliged to stop the systemic medication due to the gastro-intestinal side effects, although the laboratory investigations were all within normal limits.
 |
 |
REFERENCES
1. Chiriac A, Foia L, Pinteala T, Chiriac AE: Acne inversa (Hurley clinical stage II): case report. Our Dermatol Online. 2011;2:215-6.
Comments are closed.